Hypomorphic mutations of the MRE11 gene are the hallmark of the radiosensitive ataxiatelangiectasia-like disorder (ATLD). Here we describe a new family with two affected siblings, ATLD5 and ATLD6, now aged 37 and 36 respectively. They presented with late onset cerebellar degeneration slowly progressing until puberty and absence of telangiectasias and were cancer-free.
INTRODUCTION
Ataxia-Telangiectasia (A-T) is a pleiotropic autosomal recessive disorder characterized by cerebellar ataxia, teleangiectasias, immunodeficiency, radiosensitivity and predisposition to malignancy. Milder A-T cases, termed A-T Variants, present later onset of the disease and/or moderate severity of clinical features and longer life span (1-3).
The common phenotypic features of classical A-T and A-T Variants are hypersensitivity to ionizing radiation and radiomimetic drugs, defective cell cycle checkpoints and alterations of DNA doublestrand breaks (DBSs) repair, altogether contributing to genomic instability and cancer predisposition. Classical A-T patients show homozygous or compound heterozygous mutations of the ATM gene, that generally lead to the truncation of the protein product (4) (5) (6) (7) (8) (9) . ATM mutations were also described in some A-T Variants and in one A-T Fresno patient (10) .
More recently, four probands belonging to two unrelated English families with A-T variant phenotype, defined as A-T like disorder (ATLD), have been found to carry mutations in the MRE11
gene (11) . Of these, family 1 probands (ATLD1 and ATLD2) are affected by a severe form of the disease and carry homozygous MRE11 mutations that lead to low levels expression of truncated protein. Family 2 probands (ATLD3 and ATLD4) are affected by a milder form of the disease and carry compound heterozygous MRE11 mutations that lead to the expression of a partially active Mre11 protein (11) .
The MRE11 gene encodes a protein with nuclease and intrinsic DNA binding activity that, through interaction with Rad50 and Nbs1, forms the core of the MRN complex involved in DSB sensing, DNA recombination and multiple cell cycle checkpoints (12, 13) . The MRN complex proteins are homogeneously diffuse in the nucleus of normal undamaged cells, but after treatment with genotoxic agents are rapidly recruited at sites of DNA lesions, giving rise to the formation of nuclear foci believed to play a role in DSBs processing and checkpoints signalling (13) . In ATLD cells, where the MRE11 mutations result in reduced expression of Mre11 as well as of Rad50 and Nbs1 proteins, the formation of MRN foci is impaired. The recently generated Mre11
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at Pennsylvania State University on http://hmg.oxfordjournals.org/ Downloaded from mice expressing the ATLD1 allele (1897 C→T, R633X) appear to recapitulate the phenotypic features of ATLD, including radiation hypersensitivity, chromosomal instability and defective arrest at G1-S, intra-S and G2-M checkpoints (14) . Interestingly, these Mre11 ATLD1/ATLD1 mice are not prone to malignancy, indicating that the observed phenotypic defects are per se insufficient to significantly enhance the initiation of tumorigenesis (14) .
The response to DSBs primarily involves the activation of ATM kinase and phosphorylation of several targets, eg: p53, Chk2, Brca1, Smc1, Nbs1, critical for cell cycle checkpoint activation, DNA repair and apoptosis (15) . Although the MRN complex is a target of ATM kinase, at least two Here we describe two siblings, ATLD5 and ATLD6, presenting with a slowly progressive neurological syndrome initailly diagnosed as Ataxia without Telangiectasia [A(-T)], who have germline mutations of the MRE11 gene. They were shown to be compound heterozygotes for mutations 1422C→A, resulting in base exchange T481K, and 1714C→T, which generates a stop signal at codon 571X. Interestingly, the paternally inherited mutant allele 1714C→T is subjected to nonsense-mediated mRNA decay (NMD), as detected in an unrelated English ATLD family (patients ATLD3 and ATLD4) with the same mutation (18) . NMD is a cellular surveillance mechanism that in most vertebrates selectively degrades mRNAs with premature termination codons, reducing the amount of non-functional mRNA that would produce truncated proteins potentially exerting dominant negative effects (19, 20) . Cells from our patients show a number of
RESULTS

Description of patients
The affected siblings (ATLD5, a 38-year-old man, and ATLD6, a 37-year-old woman) were born to non-consanguineous parents. Their father died of stroke when 61-year-old, while their 59-year-old mother is in good health. The maternal lineage included a grandmother that died of stroke, an aunt affected by deaf-mutism and an uncle by mild oligophrenia and parkinsonism. The paternal lineage included a grandmother and her two sisters who died from stroke and a grandfather who died from bladder carcinoma.
ATLD5, the elder son, was normal until the age of 3 years, but then developed progressive unsteadiness and by 6 years of age showed diffuse cerebellar signs, i.e. ataxic gait, delayed speech and writing difficulties, choreoathetoid arm movements and oculomotor apraxia. The disease progressed slowly till the age of 14 and then stabilized. The latest neurological examination at 36 years of age showed cerebellar dysarthria, oculomotor apraxia, ataxic gait with unaided walk for few steps, choreoathethosis of the superior limbs, jerk nystagmus on horizontal and vertical gaze, dysmetria, dyskinetic movements of mouth and slight dystonia of the hands, diffuse hypotonia, reduced tendon reflexes in the arms, absent ankle jerks with flexor plantar responses.
ATLD6, the younger sister, had a normal psychomotor development, but by 6 years of age had acquired unsteadiness and writing difficulties. The progression of the disease was similar to her brother and resulted in dystonic movements of the face and hands along with cerebellar ataxia, ocular apraxia and cerebellar dysarthria.
Laboratory findings, including immunoglobulins, alphafetoprotein, lysosomial enzymes, lipoproteins and vitamin E levels, were in the normal range for both patients; EMG revealed a slight motor sensory neuropathy. Repeated CT Scans performed in both patients at various times showed cerebellar atrophy with a moderate size increase of the fourth ventricle, subsequently confirmed by brain MRIs.
Identification of MRE11 mutations
The search for ATM and NBS1 gene mutations failed to reveal any alterations. However, sequence analysis of the cDNAs revealed an MRE11 missense mutation at codon 1442 (C→A; T481K) (Fig   1) , also detected in the maternal cDNA. As the expression of the inherited paternal allele was undetectable, the search for mutations was performed on the genomic DNA by sequencing each of the MRE11 exons. This led to the identification of a single C→T base change in exon 15, corresponding to nucleotide 1714 in the cDNA sequence, that introduces a premature stop codon (R571X) predicted to encode a prematurely truncated protein of 65kDa. However, such product was not detected in western blots of cell lysates from both patients, suggesting that the 1714 C→T allele might undergo the nonsense-mediated mRNA decay. This appeared to be the case, since the cDNA carrying the 1714 C→T mutation was detected only after prevention of NMD by treatment of cells with anisomycin (Fig 1) . When examined by Protein Truncation Test (PTT) this transcript encoded the expected truncated Mre11 protein of 65kDa (data not shown). In summary, ATLD5
and ATLD6 are compound heterozygotes for MRE11 gene mutations [1422C→A, T481K;
1714C→T, R571X], and are null for the expression of the paternal allele because of NMD.
Radiosensitivity findings
Chromosomal breakage tests performed on peripheral blood lymphocytes from ATLD5 and ATLD6
showed an increased rate of radioinduced breaks (respectively 27 and 25 cells with breaks on 50 cells examined), intermediate between normal (16+2) and A-T (34+5) cells. No clonal chromosomal abnormalities, like the t(7;14) translocation typical of A-T, were detected, and the rate of spontaneous chromosome breakage was within the normal range. Colony survival assays performed on the LCLs established from ATLD5 and ATLD6 showed an increased sensitivity to 1Gy of irradiation, relative to normal cells (Fig 2) . Nevertheless, their radiosensitivity was less pronounced compared with ATLD4 and ATLD2, the two previously reported cases with mild and severe clinical features, respectively (11) . 
Expression of the MRN complex proteins and ATM-dependent responses to radiation
Immunoblots were performed to determine the level of ATM, Mre11, Nbs1 and Rad50 proteins in our ATLD cases also in comparison with the English cases. Both ATLD5 and ATLD6, like ATLD2
and ATLD4, expressed normal levels of ATM protein, a finding consistent with the failure to detect ATM mutations in these cases. Conversely, the levels of Mre11 as well as those of Rad50 and Nbs1
were significantly reduced in ATLD5 and ATLD6, as in ATLD4 (Fig 3) . ATLD2 appeared negative for Mre11 and Rad50, whereas it showed residual levels of Nbs1 protein (Fig 3) . Thus, the underlying genetic defect in ATLD5 and ATLD6 compromises the expression of the MRN complex components almost to the same extent as in ATLD4, but less severely than in ATLD2.
The MRN complex is recruited, along with other recognition and repair proteins, at sites of DSBs giving rise to nuclear foci (21) . As MRE11 mutations can impair the function and localization of MRN complex (11), we determined the capacity of ATLD5 and ATLD6 to form nuclear foci.
Compared with normal cells, in which the constitutively diffuse Mre11 nuclear fluorescence became localized in foci after irradiation, ATLD5 and ATLD6, besides showing a reduced Mre11 fluorescence, failed to form foci after irradiation, compatible with a defective MRN complex in these cells (Fig 4) .
Since the DNA damage-induced ATM activity, as monitored by the autophosphorylation of S1981, is markedly attenuated in ATLD (16, 22) , we determined occurrence of this defect in our ATLD cases at 30min post-irradiation. Compared with normal cells, the ATM pS1981 signal detected in ATLD5 and ATLD6 resulted reduced by 50% after 0.25Gy and 30-40% after 1Gy (Fig 5A) , to almost the same extent as in ATLD4. The ATM pS1981 signal was even more attenuated in ATLD2 and undetectable in AT. Thus, the activation of ATM in our cases is only partially impaired.
To determine the effect of this attenuated activity of ATM, we analysed the phosphorylation of its downstream targets Chk2, p53 and Smc1. The initial phosphorylation of Chk2 on Thr68 by ATM triggers additional phosphorylation steps that fully activate Chk2 (23 Chk2 is impaired in NBS cells with defects of the MRN complex due to inactivating mutations of NBS1 gene (24) . In response to IR doses >1Gy, ATLD5 and ATLD6 lymphoblastoid cells showed a similar phosphorylation-related Chk2 mobility delay as normal cells, and this delay was also seen in ATLD4, but not ATLD2 or AT cells (Fig 5B) . Strikingly, however, the Chk2 mobility delay in ATLD5 and ATLD6 appeared cell type specific as it was absent in the irradiated fibroblasts from these patients (Fig 5C) .
The phosphorylation of p53-Ser15 was analysed at 30 min post-IR, a time point when this event mostly reflects the activity of ATM, rather than ATR (25, 26) . To assess Ser15 phosphorylation independently of changes in p53 protein levels, prior to irradiation the cells were treated with the proteasome inhibitor LLnL to allow the accumulation of basal p53 (26) . The results (Fig 6) showed an 8-9 fold increase in p53-pS15 levels in normal cells, and only 1.2 fold in A-T cells, relative to the untreated cell counterparts. In ATLD5 and ATLD6 cells, the phosho-Ser15 levels increased 5.2-5.8 fold, as in NBS cells, whereas in ATLD4 and ATLD2 increased 3.1 and 2.3 fold, respectively.
ATM phosphorylates Smc1-S966, and this event is required for the radiation-induced S phase cell cycle checkpoint arrest (27) . Compared with untreated cells, the S966 phosphorylation signal in ATLD5 and ATLD6 at 30 min after irradiation was lower than in LBC-N (1.9, 1.7 and 5.5 fold increase, respectively), but this difference was not seen at 60 min (Fig 7A) . However, ATLD2, and to a lesser extent ATLD4, showed a defective S966 phosphorylation at both time points (Fig 7B) .
Flow cytometric cell cycle analyses were performed to determine the outcome of the defective ATM-p53 response on G1 checkpoint arrest. At 24hrs post irradiation, normal cells showed a slightly reduced G1/G2-M ratio that was compatible with a normal G1 checkpoint, whereas A-T cells showed a marked drop of G1 phase cells (thus causing an inversion of the G1/G2-M ratio)
indicative of a failure to arrest in G1 (Fig 8 and Table 2 ). Compatible with a defective G1 arrest, ATLD5 and ATLD6 cells showed an inversion of the G1/G2-M ratio (0.86+0.15 and 0.77+0.11, respectively). ATLD2, but not ATLD4 showed a similar defect (Fig 8) . Consistent with this diagnosis, these cancer-free patients did not exhibit ocular telangiectasias and presented with mild and slowly progressing neurological dysfunctions that manifested when they were 3 years old and stabilized when 14. Analysis of the samples from their parents showed that the 1422C→A allele, which causes a T→K aminoacid change at codon 481, was inherited from the mother, whereas the 1714C→T allele, which results in a premature stop at codon 571, was paternally inherited. Interestingly, the 1714C→T mutation could be only detected from the sequencing of genomic DNA but not from cDNA, suggesting that this mutation destabilizes the transcript by NMD. This was indeed the case, since the cDNA with the 1714C→T mutation was recovered from cells treated with anysomicin, a drug that prevents mRNA decay. Worthnoting, the 1714C→T allele is the same identified in an unrelated English family (patients ATLD3 and ATLD4) (11) , and also in these cases the transcript is subjected to NMD (18) . NMD is a surveillance mechanism which eliminates the errors in the biogenesis of mRNA (20, 30, 31) . The decay of the transcripts containing premature termination codons prevents the expression of potentially deleterious truncated proteins, mitigating the clinical severity (19) . MRE11 is an essential gene for survival and, although the six patients reported to date show variable degrees of clinical severity as well as different amount of Mre11 protein, the milder cases, albeit unrelated, share the same 1714C→T null mutation, suggesting that NMD plays a role in saving potentially lethal mutations.
The MRE11 mutations in our ATLD cases impaired not only the expression of Mre11, but also of Rad50 and Nbs1 proteins, to the same extent as in ATLD4, but not as much as in ATLD2, where these proteins were almost undetectable (11) . Furthermore, these MRE11 mutations conferred partial radiosensitivity, as demonstrated by colony survival assays, and disrupted the activity of the MRN complex to form nuclear foci in response to radiation.
The MRN complex, besides being a target of ATM, is a direct inducer of ATM kinase. Accordingly, in Mre11-deficient ATLD cells the autophosphorylation of ATM S1981 was found markedly attenuated compared with normal cells, and this defect could be corrected by wild type MRE11 (16) . Biochemical studies have further substantiated the role of MRN in ATM activation (17) . The attenuated activation of ATM in ATLD cells, resulting in a defective phosphorylation of ATM targets, actually provides an explanation for the phenotypic similarities between A-T and ATLD (16) . The autophosphorylation of ATM-S1981 in irradiated ATLD5 and ATLD6 was attenuated, though not as markedly as in A-T or ATLD2 cells. This attenuation was associated with reduced phosphorylation of p53-S15, an event involved in p53 stabilization and transcriptional induction of its target gene p21 waf1 , a key inhibitor of the G1-S checkpoint (25) . This defective phosphorylation of p53 correlated with failure of our ATLD cases to properly enforce a G1 arrest after irradiation.
Chk2, a kinase involved in multiple cell cycle checkpoints arrest after DNA damage (32) , is targeted by ATM on T68, and this event triggers the hyperphosphorylation and full activation of Chk2. We have shown a normal hyperphosphorylation of Chk2 in LCLs from ATLD5 and ATLD6, indicating that ATM, despite its reduced activity, is able to activate Chk2. Interestingly, however, the hyperphosphorylation of Chk2 was impaired in the fibroblasts from these cases, suggesting that the efficiency of ATM or access to its substrates may somehow exhibit a tissue specificity.
The phosphorylation of Smc1-S966 by ATM is required for the radiation-induced S phase cell cycle checkpoint arrest (27) . We have shown that the phosphorylation of this target of ATM is delayed in 
MATERIAL AND METHODS
Cell lines and treatments
Lymphoblastoid cell lines (LCLs) were established by EBV-immortalization of peripheral blood lymphocytes from ATLD5 and ATLD6. Normal cells (LBC-N) were obtained from a normal donor;
A-T cells from patient AT52RM (34) . The LCLs from ATLD2 and ATLD4 have been described (11) . The NBS-derived cell line GM07078 was purchased from Coriell Cell Repository (Camden, N.J.). Skin biopsies from ATLD5 and ATLD6 were used to generate fibroblast cell lines. Cells were cultured at 37°C in a CO 2 incubator using RPMI 1640 supplemented with 15% of heat inactivated fetal calf serum, 1% of glutamine and antibiotics.
Radiosensitivity analysis
Chromosome breakage analysis were performed on peripheral lymphocytes from patients and normal age-and sex-matched controls. Cells were irradiated in the G 2 phase with 0.25Gys delivered at a rate of 70cGy/min with a Gilardoni MGL 300/6-D X-ray apparatus. After addition of colcemid and incubation for 90 min, cells were used to prepare chromosome spreads on slides.
After Giemsa staining, chromatid and chromosome breaks, rings and dicentric chromosomes on 50 cells were scored by two operators for each treatment. GTG banding was performed to evaluate clonal rearrangements involving chromosomes 7 and 14. The colony survival assay and colony efficiency calculations were performed as reported (35) 
